Epic Corporation Stock Other OTC
Equities
US29428L2051
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
Financials (USD)
Sales 2008 | 22.12K | Sales 2009 | 5.22K | Capitalization | 563K |
---|---|---|---|---|---|
Net income 2008 | - | Net income 2009 | - | EV / Sales 2008 | 33.3 x |
Net Debt 2008 | 399K | Net Debt 2009 | 673K | EV / Sales 2009 | 237 x |
P/E ratio 2008 |
-0.98
x | P/E ratio 2009 |
-1.34
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
1st Jan change | Capi. | |
---|---|---|
+64.92% | 10.11B | |
+57.48% | 2.31B | |
+52.06% | 486M | |
-52.06% | 456M | |
+163.23% | 456M | |
-57.65% | 307M | |
-62.51% | 142M | |
-.--% | 121M | |
-32.20% | 96.93M |